Mitesh

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video introducing the Pricing Audit Team (PAT). The Pricing Audit Team undertake monthly audit checks to verify the accuracy of NHS pricing across prescriptions and the Margin Survey. For prescription pricing, pharmacy accounts are audited [...]

The post Funding & Reimbursement Shorts: Introduction to Pricing Audit Team appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (26/06/2025) confirmed the following list of price concessions for June 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £75.25 Alendronic acid 70mg tablets 4 £0.99 Buprenorphine 2mg sublingual tablets sugar free 7 £1.48 Buprenorphine 8mg sublingual tablets sugar free 7 £4.59 Carbocisteine 375mg capsules [...]

The post June 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches MSN/2025/038 Tier 2 – medium impact Date of issue: 19/06/2025 Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August [...]

The post Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...]

The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.